Spikevax JN.1 (mRNA-1273.167), 0.10mg/ml, Dispersion zur Injektion
7680697880012
CH-69788
0.10mg/ml, Dispersion zur Injektion
Associated product:
SPIKEVAX JN.1 ser pré 0.5 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Fertigspritze(n)
- Galenic form
- 0.10mg/ml, Dispersion zur Injektion
- Galenic group
- Unknown
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SARS-CoV-2 JN.1 mRNA
|
50.0 UG | Substance | Wirkstoff (Principe actif) |
|
heptadecan-9-ylis 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)-octanoas
|
- | Substance | HNIDK |
|
cholesterolum
|
- | Substance | HNIDK |
|
1,2-distearoyl-sn-glycero-3-phosphocholinum
|
- | Substance | HNIDK |
|
1,2-dimyristoyl-rac-glycero-3-polyethylenglycoli 2000 aether methylicus
|
- | Substance | HNIDK |
|
trometamolum
|
- | Substance | HNIDK |
|
trometamoli hydrochloridum
|
- | Substance | HNIDK |
|
acidum aceticum
|
- | Substance | HNIDK |
|
natrii acetas trihydricus
|
- | Substance | HNIDK |
|
saccharum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
0.017 MG | Substance | HBESI |
Authorization holder
Moderna Switzerland GmbH
4052 Basel
Authorization information
- Swissmedic authorization number
- 69788
- Drug name
- Spikevax JN.1 (mRNA-1273.167), Dispersion zur Injektion
- Galenic form
- DISIJ
- ATC Code
- J07BX
- Authorization status
- Revoked/Withdrawn
- Dispensing category
- B
- First authorization
- 09/09/2024
- Authorization expiration date
- 10/12/2025
- IT Number
- 08.08.
- Domain
- Human medicine
Package details
- Description (FR)
- SPIKEVAX JN.1 ser pré 0.5 ml
- Description (DE)
- SPIKEVAX JN.1 Fertspr 0.5 ml
- Market launch
- 09/09/2024
- Market withdrawal
- 01/09/2025
- Narcotic (BTM)
- No
Other package sizes (1)
SPIKEVAX JN.1 ser pré 10 x 0.5 ml
10 FESP
GTIN: 7680697880029